Zydus Wellness Q1 net profit up 1.8% to Rs 25.73 cr

Shares of Zydus Wellness today closed at Rs 1,502.35 per scrip on BSE, up steep 5.10 per cent from its previous close. 

Zydus Wellness Q1 net profit up 1.8% to Rs 25.73 cr
Representational Image: Photo: Youtube

Consumer products firm Zydus Wellness today reported a 1.8 per cent rise in its consolidated net profit to Rs 25.73 crore for the quarter ended June 30, 2018.

The company had posted a net profit after tax and non-controlling interests of Rs 25.27 crore for the corresponding period of the previous fiscal, Zydus Wellness said in a filing to BSE.

Consolidated total revenue of the company stood at Rs 152.82 crore for the quarter under consideration. It was Rs 141.86 crore for the same period a year ago.

"During the quarter, the company's pillar brands, Sugar Free, EverYuth and Nutralite continued to grow at a consistent pace," Zydus Wellness said.
Shares of Zydus Wellness today closed at Rs 1,502.35 per scrip on BSE, up steep 5.10 per cent from its previous close. 

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

RECOMMENDED STORIES

https://www.zeebiz.com/personal-finance/photo-gallery-rs-3500-monthly-sip-for-35-years-vs-rs-35000-monthly-sip-for-16-years-which-can-give-you-higher-corpus-in-long-term-compound-interest-benefits-mutual-fund-return-calculator-retirement-planning-334249

Rs 3,500 Monthly SIP for 35 years vs Rs 35,000 Monthly SIP for 16 Years: Which can give you higher corpus in long term? See calculations

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-how-long-it-will-take-to-build-rs-5-crore-corpus-target-with-inr-5000-10000-and-15000-monthly-investment-retirement-planning-with-sip-calculator-market-linked-return-334417

Power of Compounding: How long it will take to build Rs 5 crore corpus with Rs 5,000, Rs 10,000 and Rs 15,000 monthly investments?

https://www.zeebiz.com/personal-finance/photo-gallery-ppf-interest-rate-maturity-retirement-corpus-planning-calculator-how-to-get-inr-rs-72000-month-tax-free-income-from-public-provident-fund-calculations-80c-tax-benefits-333983

PPF Calculations: How to get Rs 72,000 a month tax-free income from Public Provident Fund?

https://www.zeebiz.com/personal-finance/news-rs-1111-monthly-sip-for-40-yrs-11111-for-20-yrs-or-22222-for-10-years-which-works-best-at-same-expected-return-334395

Small SIP, Big Impact: Rs 1,111 monthly SIP for 40 years, Rs 11,111 for 20 years or Rs 22,222 for 10 years, which do you think works best?

https://www.zeebiz.com/market-news/news-short-term-investment-ideas-stocks-to-buy-for-15-days-axis-direct-recommends-fortis-healthcare-aegis-logistics-check-targets-334316

Looking for short term investment ideas? Analysts suggest buying these 2 stocks for potential gain; check targets

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-fd-and-senior-citizen-savings-scheme-interest-rate-calculator-know-which-guaranteed-return-will-provide-better-income-quarterly-on-rs-20-lakh-investment-in-five-years-calculations-inside-334063

SCSS vs FD: Which guaranteed return scheme will give you more quarterly income on Rs 20,00,000 investment?

https://www.zeebiz.com/personal-finance/photo-gallery-sbi-444-day-special-fd-vs-pnb-400-day-fixed-deposit-interest-rate-maturity-calculator-what-will-general-senior-citizens-get-in-return-on-inr-rs-350000-700000-investments-in-guaranteed-fixed-income-333262

SBI 444-day FD vs PNB 400-day FD: Here's what general and senior citizens will get in maturity on Rs 3.5 lakh and 7 lakh investments in special FDs?

https://www.zeebiz.com/personal-finance/photo-gallery-power-of-compounding-how-soon-will-monthly-sip-of-rs-11000-reach-rs-8-crore-corpus-target-retirement-financial-planning-with-sip-calculator-334296

Power of Compounding: How soon will monthly SIP of Rs 11,000 reach Rs 8 crore corpus target?

Written By: PTI
Updated: Fri, Aug 03, 2018
05:33 PM IST
PTI
RELATED NEWS
Zydus Lifesciences shares surge on USFDA nod for generic drug Zydus Lifesciences shares surge on USFDA nod for generic drug
Zydus Lifesciences gets USFDA tentative nod for two generic drugs Zydus Lifesciences gets USFDA tentative nod for two generic drugs
Pharma stocks in focus: Cipla, Zydus Wellness, Torrent Pharma surge up to 5% after healthy Q1 results – brokerages recommend this Pharma stocks in focus: Cipla, Zydus Wellness, Torrent Pharma surge up to 5% after healthy Q1 results – brokerages recommend this

By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.

x